FRIEDMAN PAUL A
SEC insider (Form 3/4/5 filer). CIK 0001236927. Director at Prelude Therapeutics Inc (PRLD) and 1 other issuer. 89 reported Form 4/5 transactions since Sep 2024; latest on Jun 9, 2026. Located in WILMINGTON, DE.
Companies FRIEDMAN PAUL A has filed insider reports for
- Prelude Therapeutics Inc (PRLD): Director
- MADRIGAL PHARMACEUTICALS, INC. (MDGL): Director
FRIEDMAN PAUL A
CIK: 0001236927
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (89 total)
- Jun 9, 2026PRLD
Prelude Therapeutics Inc
AwardDirectDirector Stock Option (Right to Buy)
38K shares- - Jan 9, 2026MDGL
MADRIGAL PHARMACEUTICALS, INC.
ExerciseDirect280 shares at avg. $15.80$4K - Jan 9, 2026MDGL
MADRIGAL PHARMACEUTICALS, INC.
SaleDirect280 shares at avg. $551.24$154K - Jan 9, 2026MDGL
MADRIGAL PHARMACEUTICALS, INC.
SaleDirect1.5K shares at avg. $511.98$758K - Jan 9, 2026MDGL
MADRIGAL PHARMACEUTICALS, INC.
ExerciseDirect24.5K shares at avg. $15.80$387K - Jan 9, 2026MDGL
MADRIGAL PHARMACEUTICALS, INC.
SaleDirect1.1K shares at avg. $513.11$561K - Jan 9, 2026MDGL
MADRIGAL PHARMACEUTICALS, INC.
SaleDirect2K shares at avg. $515.81$1.0M - Jan 9, 2026MDGL
MADRIGAL PHARMACEUTICALS, INC.
SaleDirect1.3K shares at avg. $514.68$692K - Jan 9, 2026MDGL
MADRIGAL PHARMACEUTICALS, INC.
SaleDirect766 shares at avg. $516.84$396K - Jan 9, 2026MDGL
MADRIGAL PHARMACEUTICALS, INC.
SaleDirect2.5K shares at avg. $517.86$1.3M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 9, 2026 |  PRLD Prelude Therapeutics Inc | Award Director Stock Option (Right to Buy) | 38,000 | - | - | Direct |
| Jan 9, 2026 |  MDGL MADRIGAL PHARMACEUTICALS, INC. | Exercise | 280 | $15.80 | $4,424 | Direct |
| Jan 9, 2026 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sale | 280 | $551.24 | $154,348 | Direct |
| Jan 9, 2026 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sale | 1,480 | $511.98 | $757,727 | Direct |
| Jan 9, 2026 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Exercise | 24,520 | $15.80 | $387,416 | Direct |
| Jan 9, 2026 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sale | 1,094 | $513.11 | $561,340 | Direct |
| Jan 9, 2026 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sale | 1,996 | $515.81 | $1,029,561 | Direct |
| Jan 9, 2026 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sale | 1,345 | $514.68 | $692,246 | Direct |
| Jan 9, 2026 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sale | 766 | $516.84 | $395,896 | Direct |
| Jan 9, 2026 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sale | 2,450 | $517.86 | $1,268,755 | Direct |
1-10 of 89 transactions